State medical and health principal, Private university in Providence, Rhode Island

New York, July 11 Covid booster doses are more effective in people with hematologic malignancies or blood cancers including leukaemia, lymphoma, and multiple myeloma – and improves their antibody levels than initial shots, finds a study.People with blood cancers have an impaired immune system due to their disease and its treatment, which increases their risk of severe Covid-19 infection and experiencing a reduced response to Covid-19 vaccination.The study, published in the peer-reviewed journal CANCER, showed that less than half of patients with hematologic malignancies mounted detectable antibodies after initial Covid vaccination, but 56 per cent of 'nonresponders' produced antibodies after receiving a booster dose."Our findings build on the wealth of literature showing that patients with hematologic malignancies have an impaired response to Covid vaccination. Importantly, we show that many of these patients who did not respond initially will in fact have a response to booster vaccination," said Thomas Ollila, from the Brown University in the US.For the study, researchers retrospectively analysed antibody responses to initial and booster Covid-19 vaccination in 378 patients with hematologic malignancies.Anti-SARS-CoV-2 antibodies were detected in the blood of 181 patients (48 per cent) after initial vaccination. Patients with active cancer or those recently treated with an immune cell-depleting therapy were least likely to produce these antibodies. Of these, 56 per cent went on to have the antibodies after boosters.About 33 patients developed a Covid infection, with three Covid-19-related deaths. Although there was no significant link between post-vaccination antibody response and incidence of Covid infection, no patient with antibody responses died from Covid-19.Also, no patient who received the antibody therapy tixagevimab plus cilgavimab (packaged in Evusheld) by AstraZeneca was diagnosed with a Covid-19 infection. The antibody therapies bind to non-overlapping portions of the SARS-CoV-2 spike protein, preventing the virus from binding to and infecting cells."When we looked at outcomes, we found that deaths from Covid-19 in the patient population we reviewed only occurred in those with undetectable antibodies, and nobody who received prophylactic antibody therapy was diagnosed with Covid-19. This suggests to us the importance of checking antibody levels in these patients and arranging prophylactic antibody therapy," Ollila said.Ollila encouraged providing booster vaccines for patients and prioritising prophylactic antibody therapy when indicated. "This is real world evidence that these actions can save lives," he said.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

State Medical And Health PrincipalFOLLOW

State medical and health principal, Latest News

Mumbai, Jan 19 Billionaire industrialist Mukesh Ambani and Nita Ambanis son Anant Advani got formally engaged with Radhika ... ...

Mumbai, Dec 29 Industrialist Mukesh Ambani and Nita Ambani's son Anant Ambani got engaged to Radhika Merchant, daughter ... ...

Older people with hypothyroidism, also called underactive thyroid, may be at increased risk of developing dementia, according to a ... ...

If you've ever had the feeling that your elementary school kids were "smarter" than you or at least capable ... ...

New York, Oct 28 NASA's InSight lander has captured a stunning meteoroid impact on Mars that occurred last ... ...

Washington, Sep 20 NASA's InSight lander has detected impact sounds from four space rocks that crashed on Mars ... ...

India and Pakistan both celebrated their 75 years of Independence however, both nations have evolved very differently. While democracy thrived in India, Pakistan alternated between civilian and military regimes since its Independence. ...

New York, July 11 Covid booster doses are more effective in people with hematologic malignancies or blood ... ...